Stem Cell Transplantation clinical trials

Explore recruiting stem cell transplantation clinical trials.

Recruiting stem cell transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stem Cell Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II multicenter study of carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy, followed by high-dose therapy with melphalan and autologous peripheral blood stem cell transplantation, consolidation with KRd, and maintenance with lenalidomide and dexamethasone in patients ≤ 70 years old with smoldering multiple myeloma (SMM) with high risk of progression to symptomatic myeloma

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologic safety.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Czechia, Ireland, Hungary, Finland, Denmark, Norway +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

TCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neuroblastoma

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of RVU120 in Combination with Venetoclax in Participants with Acute Myeloid Leukemia Who Failed Prior Therapy with Venetoclax and a Hypomethylating Agent (RIVER-81)

Italy, Poland, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Stem Cell Transplantation trials by city

Stem Cell Transplantation in Toronto Stem Cell Transplantation in Vancouver Stem Cell Transplantation in Montreal Stem Cell Transplantation in Calgary Stem Cell Transplantation in Edmonton Stem Cell Transplantation in Ottawa Stem Cell Transplantation in Winnipeg Stem Cell Transplantation in Quebec City Stem Cell Transplantation in Hamilton Stem Cell Transplantation in Kitchener Stem Cell Transplantation in London Stem Cell Transplantation in Halifax Stem Cell Transplantation in New York Stem Cell Transplantation in Los Angeles Stem Cell Transplantation in Chicago Stem Cell Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease